Alpha-Klotho manufacturing progress: a short article previewing a biotech milestone in translating a longevity protein into a scalable cell therapy, highlighting manufacturing and encapsulation approaches.
Key Takeaways
- Avaí Bio completed a GMP Master Cell Bank for genetically modified cells producing alpha-Klotho
- Master Cell Bank will undergo independent testing before a Working Cell Bank is created
- Austrianova's Cell-in-a-Box encapsulation will be used to protect therapeutic cells while allowing protein release